Literature DB >> 10568510

Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine.

N G Kholodilov1, T F Oo, R E Burke.   

Abstract

We have previously shown that synuclein is upregulated in the substantia nigra following developmental lesion of the target striatum. In this model, synuclein is preferentially expressed in normal-appearing neurons, rather than those which undergo apoptosis. It has been proposed, however, that synuclein may mediate apoptosis in other contexts, such as that induced by neurotoxins. To examine this possibility, we have studied a model in which apoptosis is induced in dopamine neurons by intrastriatal injection of 6-hydroxydopamine. In this model synuclein mRNA and protein expression are not upregulated at any time point, but instead diminish as dopamine neurons die. We observe a complete dissociation between apoptotic morphology and synuclein protein expression. We conclude that synuclein is unlikely to play a direct role in apoptotic death in dopamine neurons and is more likely, in the target injury model, to play a role in protection or restoration of neurons which survive.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568510     DOI: 10.1016/s0304-3940(99)00740-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

Review 1.  Parkinson's disease: a rethink of rodent models.

Authors:  Heather L Melrose; Sarah J Lincoln; Glenn M Tyndall; Matthew J Farrer
Journal:  Exp Brain Res       Date:  2006-04-26       Impact factor: 1.972

2.  Neuromelanin enhances the toxicity of α-synuclein in SK-N-SH cells.

Authors:  Jie Li; Junfeng Yang; Peng Zhao; Shen Li; Renyun Zhang; Xiaobin Zhang; Dan Liu; Benshu Zhang
Journal:  J Neural Transm (Vienna)       Date:  2011-12-27       Impact factor: 3.575

Review 3.  Alpha-synuclein: its biological function and role in neurodegenerative diseases.

Authors:  Batia Kaplan; Vladimir Ratner; Elisha Haas
Journal:  J Mol Neurosci       Date:  2003-04       Impact factor: 3.444

4.  Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration.

Authors:  Amy B Manning-Bog; Alison L McCormack; Maya G Purisai; Laurel M Bolin; Donato A Di Monte
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

Review 5.  Neurobiology of alpha-synuclein.

Authors:  Kostas Vekrellis; Hardy J Rideout; Leonidas Stefanis
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

6.  Insights into the effects of alpha-synuclein expression and proteasome inhibition on glutathione metabolism through a dynamic in silico model of Parkinson's disease: validation by cell culture data.

Authors:  Shireen Vali; Shankar J Chinta; Jun Peng; Zeba Sultana; Neetu Singh; Purushottam Sharma; S Sharada; Julie K Andersen; M M Srinivas Bharath
Journal:  Free Radic Biol Med       Date:  2008-08-08       Impact factor: 7.376

Review 7.  Model fusion, the next phase in developing animal models for Parkinson's disease.

Authors:  Amy B Manning-Bog; J William Langston
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.